Aqr Capital Management LLC Sage Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$58.2 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $122,111 - $158,958	-7,141 Reduced 9.63%	67,042 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $1.06 Million - $3.09 Million	63,058 Added 566.81%	74,183 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $96,218 - $140,931	-2,367 Reduced 17.54%	11,125 $523,000
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $71,409 - $89,228	-1,916 Reduced 12.44%	13,492 $566,000
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $127,576 - $172,782	-3,962 Reduced 20.45%	15,408 $587,000

Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $1.24 Million - $1.66 Million	-38,353 Reduced 66.44%	19,370 $759,000
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $7.54 Million - $10.4 Million	-274,023 Reduced 82.6%	57,723 $1.83 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $4.16 Million - $6.2 Million	-135,621 Reduced 29.02%	331,746 $11 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $2.46 Million - $3.12 Million	-66,333 Reduced 12.43%	467,367 $19.9 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $14.8 Million - $21.1 Million	367,529 Added 221.18%	533,700 $23.5 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $8.54 Million - $12.3 Million	155,530 Added 1461.61%	166,171 $9.44 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $500,979 - $686,125	7,091 Added 199.75%	10,641 $796,000
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $207,355 - $316,163	3,550 New	3,550 $307,000
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $165,976 - $426,855	-2,758 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $1,262 - $1,709	9 Added 0.33%	2,758 $387,000
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $45,460 - $52,729	-288 Reduced 9.48%	2,749 $497,000
Q1 2019 May 14, 2019	SELL	$89.33 - $163.65 $640,674 - $1.17 Million	-7,172 Reduced 70.25%	3,037 $483,000
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $49,573 - $84,524	-605 Reduced 5.59%	10,209 $978,000
Q3 2018 Nov 15, 2018	SELL	$138.11 - $169.04 $3.92 Million - $4.79 Million	-28,357 Reduced 72.39%	10,814 $1.53 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $7.1 Million - $8.89 Million	-50,560 Reduced 56.35%	39,171 $6.13 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $6.35 Million - $8.02 Million	41,721 Added 86.9%	89,731 $14.5 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $1.69 Million - $4.66 Million	27,862 Added 138.29%	48,010 $7.91 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $1.24 Million - $1.78 Million	20,148	20,148 $1.26 Million

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account